Citation:Munhoz RR, Pereira AA, Sasse AD, Hoff PM, Traina TA, Hudis CA, et al 2016

Citation

Munhoz RR, Pereira AA, Sasse AD, Hoff PM, Traina TA, Hudis CA, et al. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis. JAMA Oncol 2016 Jan;2(1):65-73 Available from: http://www.ncbi.nlm.nih.gov/pubmed/26426573.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Munhoz RR, Pereira AA, Sasse AD, Hoff PM, Traina TA, Hudis CA, et al 2016	Ovarian suppression during chemotherapy	Dr Wanyuan Cui MBBS BMEDSCI FRACP	completed

Compare quality appraisals for each clinical question

• [[Clinical question:In female cancer patients does ovarian suppression with gonadotropin releasing hormone (GnRH) analogues or antagonists during chemotherapy reduce the risk of primary ovarian insufficiency?|]] (compare critical appraisals)

Cited by

1. Ovarian suppression with GnRH analogues